“…Previous meta-analyses comparing ICIs plus chemotherapy with chemotherapy alone [ 45 , 46 ], and others comparing treatment regimens for previously untreated ES-SCLC [ 47 , 48 , 49 ] have reported that the ICIs+chemotherapy group had a better efficacy profile than the chemotherapy alone group. However, to date, no study has compared OS and PFS across six therapeutic regimens, including Pem+EP, Dur+EP, Atz+EP, AP, IP, and EP, for previously untreated ES-SCLC.…”